Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. Revenue 2022–2025
Stoke Therapeutics Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Stoke Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 6.2 M, a 96.07% decrease year-over-year.
- Stoke Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 189.2 M, a 997.15% increase year-over-year.
- Stoke Therapeutics Inc. annual revenue for 2025 was 184.4 M, a 404.50% increase from 2024.
- Stoke Therapeutics Inc. annual revenue for 2024 was 36.6 M, a 316.34% increase from 2023.
- Stoke Therapeutics Inc. annual revenue for 2023 was 8.8 M, a 29.22% decrease from 2022.
- Stoke Therapeutics Inc. annual revenue for 2022 was 12.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Stoke Therapeutics Inc. Revenue — FAQ
Stoke Therapeutics Inc. (STOK) revenue over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Stoke Therapeutics Inc.'s revenue?
Stoke Therapeutics Inc. (STOK) reported revenue of $184M for fiscal 2025.
Where can I see STOK's revenue history?
The chart and table above show Stoke Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.